---
title: "PEN.US (PEN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PEN.US/news.md"
symbol: "PEN.US"
name: "PEN.US"
parent: "https://longbridge.com/en/quote/PEN.US.md"
datetime: "2026-05-20T17:04:10.610Z"
locales:
  - [en](https://longbridge.com/en/quote/PEN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PEN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PEN.US/news.md)
---

# PEN.US (PEN.US) — Related News

### [New York Life Investment Management LLC Takes $999,000 Position in Penumbra, Inc. $PEN](https://longbridge.com/en/news/287032637.md)
*2026-05-20T08:41:23.000Z*
> New York Life Investment Management LLC acquired a $999,000 stake in Penumbra, Inc. (NYSE:PEN), purchasing 3,213 shares 

### [3,550 Shares in Penumbra, Inc. $PEN Bought by Radnor Capital Management LLC](https://longbridge.com/en/news/286893569.md)
*2026-05-19T10:19:20.000Z*
> Radnor Capital Management LLC acquired 3,550 shares of Penumbra, Inc. (NYSE:PEN) valued at approximately $1.1 million du

### [Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts](https://longbridge.com/en/news/286046185.md)
*2026-05-12T06:32:49.000Z*
> Penumbra, Inc. (NYSE:PEN) has received a consensus rating of "Hold" from 17 analysts, with 14 recommending hold and 3 su

### [Boston Scientific (BSX) Valuation Check After New Atrial Fibrillation And Stroke Prevention Data](https://longbridge.com/en/news/285849085.md)
*2026-05-10T18:16:04.000Z*
> Boston Scientific (BSX) is under scrutiny following new clinical data for its FARAPULSE PFA and WATCHMAN LAAC platforms,

### [Penumbra Shareholders Approve Merger with Boston Scientific](https://longbridge.com/en/news/285568917.md)
*2026-05-07T14:04:38.000Z*
> Penumbra shareholders approved the merger with Boston Scientific during a special meeting on May 6, 2026. A quorum of 28

### [Penumbra | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 374.76 M](https://longbridge.com/en/news/285432719.md)
*2026-05-06T20:26:44.000Z*
### [Is Penumbra (PEN) Pricing In Too Much Growth After Recent Trial Developments](https://longbridge.com/en/news/284974564.md)
*2026-05-02T18:10:30.000Z*
> Penumbra (PEN) is currently priced at approximately $325.33, but recent analysis suggests it may be overvalued by 80.4% 

### [Boston Scientific Corp 1Q 2026: Revenue $5.2B, EPS $0.9— 10-Q Summary](https://longbridge.com/en/news/284907701.md)
*2026-05-01T14:01:01.000Z*
> Boston Scientific Corp reported a strong first quarter for 2026, with revenue reaching $5.2 billion and diluted EPS of $